Ranolazine Cardioprotection in PCI

NCT01767987 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Stopped Sponsor terminated study due to lack of enrollment

Conditions

Acute Coronary Syndrome

Interventions

DRUG: Ranolazine
DRUG: Placebo

Sponsor

Harvey Hahn

Collaborators

[object Object]